Seattle's Presage Biosciences has in-licensed Phase I oral cancer drug voruciclib from India's Piramal Enterprises to test its intratumoral…

Israel's Oramed has brought its oral insulin capsule into China, Hong Kong and Macau, signing an agreement this week worth up to $50 million with the…

Novo Nordisk announced an expanded drug delivery partnership with Emisphere under which the Big Pharma will develop medications for metabolic disorders like…

New Jersey's The Medicine's Co. has tied the knot with Tokyo's SymBio, a deal that gives the Japanese company the exclusive license to…

GlaxoSmithKline now has rights to develop inhaled therapeutics using Liquidia's PRINT particle engineering technology. The development builds on a drug…

As part of its so-called Base Plus Plus Plus strategy, specialty pharmaceutical company Perrigo announced that it is licensing Flamel's LiquiTime…

Aerie Pharmaceuticals will use GrayBug's micro particle-based technologies to deliver its candidates to the front and back of the eye under a just-…

Northwestern University announced that it has a received a five-year $17.5 million grant from the National Institutes of Health to study an implantable drug…

Partnering